Predictors for fibrosis regression in chronic HCV patients after the treatment with DAAS: results of a real-world cohort study
Introduction: The goal of treatment of chronic hepatitis C (HCV) is viral eradication. However,
obtaining histological regression is even more important, because it will reduce the overall …
obtaining histological regression is even more important, because it will reduce the overall …
[HTML][HTML] Hepatitis C Virus: History and Current Knowledge
S Topi, E Gaxhja, IA Charitos, M Colella… - Gastroenterology …, 2024 - mdpi.com
According to the World Health Organization (WHO), the incidence of HCV remains high
(around 1.5 million new patients every year), and 80% of patients with acute infection will …
(around 1.5 million new patients every year), and 80% of patients with acute infection will …
High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents
AY Elmowafy, HM El Maghrabi, ME Mashaly… - … Urology and Nephrology, 2019 - Springer
Abstract Background Direct-acting antivirals (DAAs) have significantly improved the efficacy
and safety of treating chronic hepatitis C (CHC), but their effectiveness and safety among …
and safety of treating chronic hepatitis C (CHC), but their effectiveness and safety among …
Antiviral drugs
E Cani, TE Park, R Kavanagh - Side Effects of Drugs Annual, 2019 - Elsevier
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. This review of the January …
effects of drugs and adverse reactions to them are surveyed. This review of the January …
[PDF][PDF] An eco-concerned development of a fast, precise and economical spectrophotometric assay for the antiviral drug simeprevir based on ion-pair formation
SH Mohamed, YM Issa, AI Salim - Biointerface Res. Appl …, 2021 - biointerfaceresearch.com
Simeprevir sodium (SMV) is one of the antiviral drugs used for the treatment of virus C. The
current strategy develops and validates a new eco-concerned tool for its quantification in the …
current strategy develops and validates a new eco-concerned tool for its quantification in the …
Differences in the course of hepatocellular carcinoma depending on the DAA treatment
A Lembas, A Załęski, T Mikuła… - Prospects in …, 2024 - prospects.wum.edu.pl
Background and aims: 58 million people live with chronic hepatitis C virus (HCV) infection
which can lead to liver cirrhosis and hepatocellular carcinoma (HCC). Currently, a non …
which can lead to liver cirrhosis and hepatocellular carcinoma (HCC). Currently, a non …
Liver Transplantation and HCV Genotype 4
S Alghamdi, W Al-hamoudi - Advances in Hepatology, 2021 - books.google.com
End-stage liver disease secondary to hepatitis C virus (HCV) infection is a major indication
for liver transplantation (LT) worldwide. Previous studies have shown a negative impact of …
for liver transplantation (LT) worldwide. Previous studies have shown a negative impact of …